Our Products


Ipratropium Bromide MIS

* Therapeutical group: Respiratory system drugs
* Composition: Ipratropium Bromide

Composition:
Ipratropium Bromide Anhydrous 250 mcg, Ipratropium Bromide Anhydrous 500 mcg.

Indications:
1. For the treatment of reversible bronchospasm associated with chronic obstructive pulmonary disease (COPD).
2. For the treatment of reversible airways obstruction as in acute and chronic asthma, when used concomitantly with inhaled beta 2-agonists.

Packaging:
Ipratropium Bromide MIS 250: Ampoule of 2 ml, 10 Ampoules/ Box. Solution for Inhalation.
Ipratropium Bromide MIS 500: Ampoule of 2 ml, 10 Ampoules/ Box. Solution for Inhalation.